MAH Expertise Across Eastern Europe — and Beyond

September 3, 2025

Business professionals working with charts graphs at a table

Navigating pharmaceutical regulations across multiple countries isn't just about knowing the rules — it's about understanding the rhythm of each market, responding quickly to change, and having the right expertise to move confidently through complex and often fragmented regulatory environments.

As a Marketing Authorization Holder (MAH) with operations throughout Eastern Europe, we've built a trusted reputation for managing regulatory responsibilities with precision, consistency, and agility. Our team's hands-on knowledge, strong local networks, and deep regional experience allow us to support clients across diverse jurisdictions — delivering seamless, compliant, and strategic regulatory solutions.

Eastern Europe: A Region of Regulatory Diversity

Eastern Europe is anything but a one-size-fits-all region. It comprises a mosaic of regulatory environments, each with its own authority structures, national policies, and procedural frameworks. Countries like Albania, Bosnia and Herzegovina, Croatia, Kosovo, Montenegro, North Macedonia, and Serbia offer unique regulatory landscapes, shaped by historical, political, and economic contexts.

Some of these countries align closely with European Union legislation, while others follow independent national standards. Even where alignment exists, implementation and interpretation often vary — creating additional complexity for pharmaceutical companies.

We understand these nuances — not just on paper, but in practice. Our team has successfully navigated:

  • Local registration procedures in both EU and non-EU markets
  • Country-specific labelling and packaging requirements
  • National timelines and dossier expectations
  • Language mandates and translation best practices
  • Complex reimbursement processes and health technology assessments (HTAs)
  • Product transfers, including legal entity changes and ownership updates

We don't simply react to regulations — we anticipate, strategize, and execute with purpose.

Our Role as a Marketing Authorization Holder

Being a MAH is more than a formal role — it's a significant legal and operational responsibility. We are accountable for the product's compliance with local laws, pharmacovigilance requirements, and marketing practices throughout its lifecycle.

Our MAH model is built on an integrated, end-to-end approach that ensures:

Regulatory Compliance

We actively monitor changes in national legislation and ensure timely implementation of updates. Whether it's pharmacovigilance reporting, promotional material review, or ensuring continued marketing authorization, we keep your product aligned with the latest requirements.

Lifecycle Management

From initial submissions to renewals and post-authorization variations, we manage every step of the product lifecycle. Our processes are designed to avoid delays and minimize risks — ensuring that your product remains continuously available and compliant.

Regulatory Intelligence

We don't wait for regulatory changes to disrupt your plans — we stay ahead of them. Our team continuously gathers insights from national authorities, industry forums, and regional trends to help you make informed decisions and proactively mitigate potential obstacles.

Cross-border Coordination

We serve as a central coordination point between headquarters, local affiliates, distributors, and regulatory bodies. This ensures that your regulatory strategy is consistent across borders, yet adaptable to local demands.

Supporting Market Entry and Expansion

Our services go beyond maintenance — we also support companies looking to enter and grow in Eastern European markets. Whether you're launching a new product or transitioning from another MAH, we provide critical guidance every step of the way.

Our offering includes:

  • Local Representation: Serving as the MAH or local regulatory representative for companies without a local legal entity.
  • Regulatory Strategy and Planning: Advising on market-specific requirements, costs, documentation needs, and estimated timelines.
  • Gap Analysis and Dossier Review: Identifying missing or non-compliant elements in your registration file before submission.
  • Regulatory Due Diligence: Supporting acquisitions, divestments, and licensing deals with in-depth regulatory reviews.
  • Product Transfer Management: Managing MAH transfers and ensuring business continuity during changes in ownership or structure.

While we don't engage in commercial activities such as distribution or sales, we offer strategic consultancy to help companies establish their local operations with clarity and confidence. We provide tailored insights into each country's regulatory and market landscape, enabling informed decisions on investment, resource allocation, and launch planning.

Expanding Beyond Eastern Europe

Our capabilities are not limited to Eastern Europe. With every new region we serve, we bring the same operational excellence, rigorous standards, and deep regulatory insight that define our work in Eastern Europe.

Whether supporting multi-market launches or acting as a regulatory partner in untapped markets, our global mindset and local execution make us the ideal MAH for companies looking to expand their reach.

We work closely with clients from a wide range of countries — including the EU, the UK, the US, and beyond — helping them navigate local regulatory frameworks with confidence and efficiency.

Why Choose Us as Your MAH Partner?

  • Trusted local and regional expertise
  • Proven success across complex regulatory systems
  • Reliable end-to-end regulatory management
  • Transparent communication and strategic thinking
  • Seamless collaboration between central and local teams

In a region known for regulatory complexity, we provide clarity. In markets where timelines shift and standards evolve, we bring stability. And when your success depends on getting it right the first time, we're the partner you can rely on.

Ready to expand your presence in Eastern Europe or beyond? Let us guide you — with the insight, precision, and partnership that only an experienced MAH can offer.

TAGS:

Expanding into Europe? Accelerate Your European Marketing Authorization

For non-European pharmaceutical companies, expanding into the European market is both an exciting opportunity and a formidable challenge. While the potential for growth is significant, so too are the...

July 21, 2025

Mastering Clinical Trial Submissions in Europe: A Guide for Drug Developers

Launching a clinical trial in Europe is a complex but rewarding endeavor, requiring careful navigation of regulatory frameworks, ethical requirements, and submission processes. Recent regulatory...

Several business professionals talking around a glass conference table

Understanding the Roles of LPPV, QPPV, and the PSMF in Pharmacovigilance: A Guide for Marketing Authorization Holders (MAHs)

In today’s stringent regulatory landscape, the effectiveness of a pharmaceutical company’s pharmacovigilance (PV) system is supported by three key pillars: the Qualified Person for Pharmacovigilance...